What medication regimen is recommended for treating a runny nose (rhinorrhea) in adults and children, considering possible allergic or viral causes?

Medication for Runny Nose (Rhinorrhea)

First-Line Treatment Recommendation

For allergic rhinorrhea, start with a second-generation oral antihistamine (cetirizine, fexofenadine, loratadine, or desloratadine) or an intranasal corticosteroid (fluticasone, mometasone, or budesonide); for non-allergic or viral rhinorrhea, use intranasal ipratropium bromide 0.03-0.06% as it specifically targets watery nasal discharge. 1, 2, 3

---

Treatment Algorithm by Cause

Allergic Rhinorrhea (Seasonal or Perennial)

Mild Intermittent Symptoms

• Start with a second-generation oral antihistamine such as fexofenadine 180 mg daily, loratadine 10 mg daily, cetirizine 10 mg daily, or desloratadine 5 mg daily 4, 1, 5
• These agents effectively reduce rhinorrhea, sneezing, and itching with minimal sedation 1, 5
• Avoid first-generation antihistamines (diphenhydramine, chlorpheniramine) due to marked sedation, cognitive impairment, anticholinergic effects, and increased fall risk, especially in older adults 1, 5

Moderate-to-Severe or Persistent Symptoms

• Intranasal corticosteroids are the most effective first-line treatment for all allergic rhinitis symptoms including rhinorrhea 4, 6, 3
• Recommended agents: fluticasone propionate 2 sprays per nostril daily (200 mcg), mometasone furoate 2 sprays per nostril daily (200 mcg), or budesonide 6, 3
• Symptom relief begins within 3-12 hours, with maximal benefit in days to weeks 6

Inadequate Response to Monotherapy

• Add intranasal antihistamine (azelastine) to the intranasal corticosteroid rather than adding an oral antihistamine 4, 6
• This combination provides >40% relative improvement compared to either agent alone 4, 6
• Do not routinely add oral antihistamines to intranasal corticosteroids—multiple trials show no additional benefit 4

Refractory Rhinorrhea Despite Combined Therapy

• Add intranasal ipratropium bromide 0.03% (2 sprays per nostril 2-3 times daily) for persistent watery discharge 4, 1, 2
• Ipratropium specifically targets rhinorrhea through anticholinergic action and is more effective than adding oral antihistamines 4, 1

---

Non-Allergic Rhinorrhea (Vasomotor, Irritant-Induced)

• Intranasal ipratropium bromide 0.03% is first-line therapy (2 sprays per nostril 2-3 times daily) 4, 1, 7
• Ipratropium effectively reduces rhinorrhea but does not improve other nasal symptoms like congestion 4, 1
• Intranasal corticosteroids can be added if symptoms are not adequately controlled 7, 3
• Intranasal antihistamines (azelastine) may be used as monotherapy or combined with intranasal corticosteroids 3

---

Viral Rhinorrhea (Common Cold)

• Intranasal ipratropium bromide 0.06% is the only FDA-approved medication for common cold rhinorrhea (2 sprays per nostril 3-4 times daily for up to 4 days) 4, 1, 2
• Antihistamines have limited benefit: they may provide short-term relief (days 1-2) but do not significantly improve rhinorrhea in the mid-to-long term 4
• Oral decongestants may provide modest subjective relief of congestion but do not specifically target rhinorrhea 4
• Intranasal corticosteroids are not recommended for symptomatic relief of the common cold 4

---

Pediatric Considerations

Children ≥6 Years

• Second-generation antihistamines: loratadine 10 mg daily or fexofenadine 30 mg twice daily 5
• Intranasal ipratropium 0.03%: 2 sprays per nostril 2-3 times daily 1, 2
• Intranasal ipratropium 0.06% (for common cold): 2 sprays per nostril 3-4 times daily for ages ≥5 years 1, 2

Children 2-5 Years

• Cetirizine: 2.5 mg once or twice daily 5
• Loratadine: 5 mg once daily 5
• Intranasal corticosteroids: triamcinolone 1 spray per nostril daily (ages ≥2 years), mometasone 1 spray per nostril daily (ages ≥2 years) 6

Children <6 Years

• Avoid first-generation antihistamines entirely—33 deaths in children <6 years attributed to diphenhydramine between 1969-2006 1
• Do not use over-the-counter cough-and-cold products containing first-generation antihistamines per FDA and AAP recommendations 1

---

Critical Safety Warnings

First-Generation Antihistamines (Diphenhydramine)

• Avoid in all patients when safer alternatives exist 1, 5
• Cause marked sedation, psychomotor impairment (even without subjective drowsiness), anticholinergic effects (dry mouth, urinary retention, constipation, increased intraocular pressure) 1, 5
• In older adults: markedly increase risk of falls, fractures, subdural hematomas, cognitive impairment, and delirium 1, 5
• Contraindications/cautions: cardiac arrhythmia, angina, cerebrovascular disease, hypertension, bladder-neck obstruction, glaucoma, hyperthyroidism 1
• Reserve only for acute severe symptoms when intranasal therapy unavailable, patient has no contraindications, and treatment limited to ≤3 days with close monitoring 1

Topical Decongestants (Oxymetazoline)

• Limit use to ≤3-5 days maximum to avoid rebound congestion (rhinitis medicamentosa) 4, 6
• May be used short-term with intranasal corticosteroids for severe nasal obstruction 4

Oral Decongestants (Pseudoephedrine)

• Use with extreme caution in patients with hypertension, cardiac arrhythmias, angina, cerebrovascular disease, hyperthyroidism, diabetes, bladder-neck obstruction, or glaucoma 4, 5
• Contraindicated with concurrent MAO inhibitor therapy 5
• Elderly patients at increased risk for cardiovascular and CNS adverse effects 5

---

Common Pitfalls to Avoid

• Do not combine intranasal corticosteroid + oral antihistamine as initial therapy—intranasal corticosteroid alone is equally effective and more cost-efficient 4, 6
• Do not use leukotriene receptor antagonists (montelukast) as primary therapy—they are markedly less effective than intranasal corticosteroids 4, 6
• Do not assume all second-generation antihistamines are equally non-sedating—cetirizine causes mild sedation in ~13.7% of patients; fexofenadine is truly non-sedating even at higher doses 1, 5
• Do not use oral antihistamines alone for nasal congestion—they have limited effect; add intranasal corticosteroid when congestion is prominent 1, 5, 6
• Do not delay intranasal corticosteroids while awaiting allergy testing—start empiric treatment immediately for moderate-to-severe symptoms 6
• Teach proper intranasal spray technique (contralateral hand, aim away from septum) to reduce epistaxis risk by fourfold 6

---

Dosing Summary

Adults – Second-Generation Antihistamines

• Fexofenadine: 180 mg once daily 1
• Loratadine: 10 mg once daily 1
• Cetirizine: 10 mg once daily 1
• Desloratadine: 5 mg once daily 1

Adults – Intranasal Ipratropium Bromide

• 0.03% spray: 2 sprays per nostril 2-3 times daily (allergic/non-allergic rhinitis) 1, 2
• 0.06% spray: 2 sprays per nostril 3-4 times daily (common cold, up to 4 days) 1, 2

Adults – Intranasal Corticosteroids

• Fluticasone propionate: 2 sprays per nostril once daily (200 mcg) 6
• Mometasone furoate: 2 sprays per nostril once daily (200 mcg) 6

Adults – Intranasal Antihistamine

• Azelastine: 1-2 sprays per nostril twice daily 8, 3